NYTNYT·3hHealth
score+0.70
Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
Original
Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
“The headline highlights positive clinical trial results reducing cancer risk, framing a scientific breakthrough as a tangible medical benefit.”